J
Jason M. White
Researcher at University of South Australia
Publications - 224
Citations - 9444
Jason M. White is an academic researcher from University of South Australia. The author has contributed to research in topics: Methadone & Methadone maintenance. The author has an hindex of 48, co-authored 217 publications receiving 8511 citations. Previous affiliations of Jason M. White include University of Adelaide & Royal Adelaide Hospital.
Papers
More filters
Journal ArticleDOI
Alpha2‐adrenergic agonists for the management of opioid withdrawal
TL;DR: Moderate-quality evidence was found that alpha2-adrenergic agonists were more effective than placebo in ameliorating withdrawal in terms of the likelihood of severe withdrawal, and peak withdrawal severity may be greater with alpha2/adrenaline agonists than with reducing doses of methadone.
Journal ArticleDOI
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability.
TL;DR: In this article, the authors examined the relationship between the prevalence and concentration of drugs and the culpability of the driver using an objective method for assessing culpability, and found a significant concentration-dependent relationship between alcohol and culpability: as blood alcohol concentration increased, so did the percentage of culpable drivers.
Journal ArticleDOI
Exposure to opioid maintenance treatment reduces long-term mortality.
TL;DR: Increased exposure to opioid maintenance treatment reduces the risk of death in opioid-dependent people and there was no differential mortality among methadone versus buprenorphine participants.
Journal ArticleDOI
New psychoactive substances: challenges for drug surveillance, control, and public health responses
Amy Peacock,Amy Peacock,Raimondo Bruno,Raimondo Bruno,Natasa Gisev,Louisa Degenhardt,Wayne Hall,Wayne Hall,Roumen Sedefov,Jason M. White,Kevin V. Thomas,Michael Farrell,Paul Griffiths +12 more
TL;DR: It is proposed that the current means of responding to emerging substances might no longer be fit for purpose in a world in which different substances can be rapidly introduced, and where people who use drugs can change preferences on the basis of market availability.
Journal ArticleDOI
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine
Mark Doverty,Andrew A. Somogyi,Andrew A. Somogyi,Jason M. White,Felix Bochner,Felix Bochner,Christopher H Beare,Andrew Menelaou,Walter Ling +8 more
TL;DR: The findings suggest that methadone patients are cross‐tolerant to the antinociceptive effects of morphine, and conventional doses of morphine are likely to be ineffective in managing episodes of acute pain amongst this patient group.